Johnson Bixby & Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$546K Buy
4,249
+31
+0.7% +$3.63K 0.06% 69
2026
Q1
$507K Sell
4,218
-13
-0.3% -$1.5K 0.06% 74
2025
Q4
$445K Sell
4,231
-177
-4% -$16.6K 0.06% 76
2025
Q3
$370K Sell
4,408
-254
-5% -$20.9K 0.05% 85
2025
Q2
$369K Hold
4,662
0.05% 81
2025
Q1
$418K Hold
4,662
0.06% 77
2024
Q4
$464K Sell
4,662
-5
-0.1% -$515 0.07% 71
2024
Q3
$530K Hold
4,667
0.08% 61
2024
Q2
$578K Hold
4,667
0.1% 60
2024
Q1
$616K Sell
4,667
-200
-4% -$24.7K 0.11% 57
2023
Q4
$531K Sell
4,867
-100
-2% -$10.4K 0.1% 60
2023
Q3
$511K Sell
4,967
-312
-6% -$33.6K 0.11% 57
2023
Q2
$609K Buy
5,279
+28
+0.5% +$3.18K 0.13% 53
2023
Q1
$559K Hold
5,251
0.12% 55
2022
Q4
$583K Sell
5,251
-94
-2% -$9.61K 0.14% 54
2022
Q3
$460K Buy
5,345
+5
+0.1% +$446 0.12% 58
2022
Q2
$487K Buy
5,340
+1,200
+29% +$106K 0.12% 57
2022
Q1
$340K Hold
4,140
0.09% 65
2021
Q4
$317K Sell
4,140
-120
-3% -$9.56K 0.08% 64
2021
Q3
$320K Sell
4,260
-95
-2% -$7.22K 0.09% 64
2021
Q2
$339K Sell
4,355
-346
-7% -$25.7K 0.1% 63
2021
Q1
$346K Sell
4,701
-88
-2% -$6.49K 0.11% 55
2020
Q4
$374K Buy
+4,789
New +$366K 0.12% 52

Other funds holding MRK

Johnson Bixby & Associates's MRK Position: Q2 2026 in Review

Johnson Bixby & Associates increased its Merck (MRK) stake by 0.73% in Q2 2026, buying an estimated $3.63K and bringing the position to 4,249 shares worth $546K. The position accounts for 0.06% of the portfolio, ranked #69.

Johnson Bixby & Associates first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. The position peaked at $616K in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Johnson Bixby & Associates held 4,249 shares of Merck worth $546K as of Q2 2026.
  • Johnson Bixby & Associates bought 31 Merck shares in Q2 2026, an estimated $3.63K.
  • Merck made up 0.06% of Johnson Bixby & Associates's portfolio in Q2 2026, its #69 holding.
  • Johnson Bixby & Associates first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
  • Johnson Bixby & Associates's Merck position peaked at $616K in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Johnson Bixby & Associates's 13F filing for Q2 2026, filed 16 Jul 2026.